There’s a paper doing the rounds about a blood marker that may independently predict longevity - independent of the usual cardiovascular and metabolic panels. I’ve been sitting with it for a few days, and my first instinct is less “exciting new biomarker” and more “this is going to have the same draw timing problem everything else does.” I’ve had bloods done on a fairly regimented schedule since 2019. Estradiol, free testosterone, SHBG, ferritin, and more recently some of the extended longevity markers that certain labs now offer. The thing that took me longer than I’d like to admit to learn: when you draw relative to your protocol changes the number significantly. With my estradiol patch - I change Sunday mornings - the difference between a Monday draw and a Saturday draw is somewhere in the range of 30-40 pg/mL. Not because anything meaningful shifted biologically. I’m just catching different points on the absorption curve. For years I wrote off inconsistent results as lab error or application variation. It was mostly timing. I suspect longevity biomarkers will run into the same issue, especially for those of us on exogenous hormones, peptides, or anything that affects inflammatory markers or metabolic signalling. The marker may be real and predictive. But if it’s responsive to cortisol rhythm, sleep quality, recent exercise, or feeding state, then the conditions around the draw matter as much as the result itself. If you’re tracking any of this seriously, I’d suggest standardising your draw conditions before drawing conclusions. Same point in your cycle or patch week, same fasting window, same time of day. Consistent protocol, consistent timing. Otherwise you’re comparing results that shouldn’t be compared at all.